Sulfated Glycans in HIV Infection and Therapy.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current pharmaceutical design

• Publication date

  2017-05-31

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/1381612823666170127113958PMID 28137224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Marine Carbohydrate-Based Compounds with Medicinal Properties

  2018cited by this paper
• Antimicrobial Sulfated Glycans: Structure and Function.

  2016cited by this paper
• The contribution of Glycobiology to the Zika outbreak in the Americas.

  2016cited by this paper
• HIV-1 Matrix Protein p17 and its Receptors.

  2015cited by this paper
• Current structural biology of the heparin interactome.

  2015cited by this paper
• Holothurian Fucosylated Chondroitin Sulfate

  2014cited by this paper
• HIV infection: epidemiology, pathogenesis, treatment, and prevention.

  2014cited by this paper
• Human Immunodeficiency Virus and Heparan Sulfate: From Attachment to Entry Inhibition

  2013cited by this paper
• The depolymerized fucosylated chondroitin sulfate from sea cucumber potently inhibits HIV replication via interfering with virus entry.

  2013cited by this paper
• Macrophages and their relevance in Human Immunodeficiency Virus Type I infection

  2012cited by this paper
• Fucanomics and galactanomics: current status in drug discovery, mechanisms of action and role of the well-defined structures.

  2012cited by this paper
• A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti- HIV-1 activity independently of coreceptor usage.

  2012cited by this paper
• Fucanomics and Galactanomics: Marine Distribution, Medicinal Impact, Conceptions, and Challenges

  2012cited by this paper
• Acute HIV-1 Infection.

  2011cited by this paper
• Heparan sulfate proteoglycans.

  2011cited by this paper
• CD4+ T Cell Depletion in Human Immunodeficiency Virus (HIV) Infection: Role of Apoptosis

  2011cited by this paper
• HIV-1 p17 Matrix Protein Interacts with Heparan Sulfate Side Chain of CD44v3, Syndecan-2, and Syndecan-4 Proteoglycans Expressed on Human Activated CD4+ T Cells Affecting Tumor Necrosis Factor α and Interleukin 2 Production*

  2011cited by this paper
• Identification of Amino Acid Residues Important for Heparan Sulfate Proteoglycan Interaction within Variable Region 3 of the Feline Immunodeficiency Virus Surface Glycoprotein

  2011cited by this paper
• Manipulation of dendritic cell function by viruses.

  2010cited by this paper
• Structural and functional insights into sulfated galactans: a systematic review

  2009cited by this paper
• Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells

  2009cited by this paper
• HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium.

  2009cited by this paper
• A synthetic CD4-heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry.

  2009cited by this paper
• HIV-1 p17 binds heparan sulfate proteoglycans to activated CD4(+) T cells.

  2008cited by this paper
• Structure, biology, evolution, and medical importance of sulfated fucans and galactans.

  2008cited by this paper
• The HIV-1 Envelope Glycoprotein gp120 Features Four Heparan Sulfate Binding Domains, Including the Co-receptor Binding Site*

  2008cited by this paper
• Binding and clustering of glycosaminoglycans: a common property of mono- and multivalent cell-penetrating compounds.

  2008cited by this paper
• Mannose-binding lectin in HIV infection.

  2008cited by this paper
• Inhibition of reverse transcriptase activity of HIV by polysaccharides of brown algae.

  2008cited by this paper
• Structural features and anti-HIV-1 activity of novel polysaccharides from red algae Grateloupia longifolia and Grateloupia filicina.

  2007cited by this paper
• HIV-1 infection of trophoblasts is independent of gp120/CD4 Interactions but relies on heparan sulfate proteoglycans.

  2007cited by this paper
• Following the path of the virus: the exploitation of host DNA repair mechanisms by retroviruses.

  2006cited by this paper
• A review of HIV‐1 Tat protein biological effects

  2005cited by this paper
• Dendritic Cell-Specific Intercellular Adhesion Molecule 3-Grabbing Nonintegrin/CD209 Is Abundant on Macrophages in the Normal Human Lymph Node and Is Not Required for Dendritic Cell Stimulation of the Mixed Leukocyte Reaction1

  2005cited by this paper
• Mannose binding lectin (MBL) and HIV.

  2005cited by this paper
• Heparan Sulfate Targets the HIV-1 Envelope Glycoprotein gp120 Coreceptor Binding Site*

  2005cited by this paper
• The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity.

  2004cited by this paper
• Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters.

  2004cited by this paper
• DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related (DC-SIGNR): friend or foe?

  2003cited by this paper
• Highly active antiretroviral therapy and beta‐chemokines

  2002cited by this paper
• Heparin and Heparan Sulfate Biosynthesis

  2002cited by this paper
• Heparin and heparan sulfate: structure and function.

  2002cited by this paper
• HIV-1 transmission and acute HIV-1 infection.

  2001cited by this paper
• The fusion domain of HIV gp41 interacts specifically with heparan sulfate on the T‐lymphocyte cell surface

  2001cited by this paper
• A Dendritic Cell–Specific Intercellular Adhesion Molecule 3–Grabbing Nonintegrin (Dc-Sign)–Related Protein Is Highly Expressed on Human Liver Sinusoidal Endothelial Cells and Promotes HIV-1 Infection

  2001cited by this paper
• Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate Proteoglycans*

  2001cited by this paper
• Optimal Inhibition of X4 HIV Isolates by the CXC Chemokine Stromal Cell-derived Factor 1α Requires Interaction with Cell Surface Heparan Sulfate Proteoglycans*

  2001cited by this paper
• Heparin and heparan sulfate: biosynthesis, structure and function.

  2000cited by this paper
• A new sulfated beta-galactan from clams with anti-HIV activity.

  1999cited by this paper
• Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.

  1999cited by this paper
• HIV-1 attachment: another look.

  1999cited by this paper
• Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

  1998cited by this paper
• Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4.

  1998cited by this paper
• HIV‐1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix‐associated heparan sulfate proteoglycans through its basic region

  1997cited by this paper
• Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans.

  1997cited by this paper
• Inhibition of HIV-1 infectivity by low molecular weight heparin

  1996cited by this paper
• CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5

  1996cited by this paper
• Human milk glycosaminoglycans inhibit HIV glycoprotein gp120 binding to its host cell CD4 receptor.

  1995cited by this paper
• Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop.

  1994cited by this paper
• Lectins in AIDS research.

  1994cited by this paper
• HIV pathogenesis and long-term survival.

  1993cited by this paper
• Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor.

  1993cited by this paper
• Cell-Surface Heparan Sulfate Proteoglycan Mediates HIV-1 Infection of T-Cell Lines

  1993cited by this paper
• Investigations into the Mechanism by Which Sulfated Polysaccharides Inhibit HIV Infection In Vitro

  1992cited by this paper
• Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions

  1991cited by this paper
• Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection

  1991cited by this paper
• Anti-human immunodeficiency virus effects of dextran sulfate are strain dependent and synergistic or antagonistic when dextran sulfate is given in combination with dideoxynucleosides

  1990cited by this paper
• Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.

  1990cited by this paper
• Pharmacokinetic Analysis of Dextran Sulfate in Rats as Pertains to Its Clinical Usefulness for Therapy of HIV Infection

  1990cited by this paper
• Anti-HIV activity of dextran sulphate as determined under different experimental conditions.

  1989cited by this paper
• Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus

  1988cited by this paper
• HEPARIN INHIBITS INFECTIVITY OF HUMAN IMMUNODEFICIENCY VIRUS IN VITRO

  1988cited by this paper
• Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro.

  1988cited by this paper
• Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro.

  1988cited by this paper
• Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro.

  1987cited by this paper

• T Cell Activation Induces Synthesis of CD47 Proteoglycan Isoforms and Their Release in Extracellular Vesicles

  2025cites this paper
• Pathogens that infect mammalian cells via sulfonated glycosaminoglycans

  2025cites this paper
• Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants.

  2023cites this paper
• Harnessing Human Papillomavirus’ Natural Tropism to Target Tumors

  2022cites this paper
• Polymers Inspired by Heparin and Heparan Sulfate for Viral Targeting

  2022cites this paper
• Red Algal Sulfated Galactan Binds and Protects Neural Cells from HIV-1 gp120 and Tat

  2021cites this paper
• Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2

  2021cites this paper
• Lignosulfonate Rapidly Inactivates Human Immunodeficiency and Herpes Simplex Viruses

  2021cites this paper
• Advances in Antiviral Material Development

  2020cites this paper
• Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?

  2019cites this paper
• Advancing MSn spatial resolution and documentation for glycosaminoglycans by sulfate-isotope exchange

  2019cites this paper
• The neutralization of heparan sulfate by heparin-binding copolymer as a potential therapeutic target

  2019cites this paper
• Marine Carbohydrate-Based Compounds with Medicinal Properties

  2018cites this paper
• Mapping of the Fondaparinux Binding Site of JR-FL gp120 by High Resolution Hydroxyl Radical Protein Footprinting and Computational Docking

  2017cites this paper